Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Non-Current Deferred Tax Liability (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Non-Current Deferred Tax Liability for 15 consecutive years, with $4.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 5.5% to $4.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.5 million, a 5.5% decrease, with the full-year FY2024 number at $4.1 million, down 10.52% from a year prior.
  • Non-Current Deferred Tax Liability was $4.5 million for Q3 2025 at Usana Health Sciences, down from $4.7 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $35.7 million in Q1 2022 to a low of $4.1 million in Q4 2022.
  • A 5-year average of $7.6 million and a median of $4.8 million in 2022 define the central range for Non-Current Deferred Tax Liability.
  • Biggest YoY gain for Non-Current Deferred Tax Liability was 197.11% in 2022; the steepest drop was 88.59% in 2022.
  • Usana Health Sciences' Non-Current Deferred Tax Liability stood at $7.8 million in 2021, then tumbled by 48.07% to $4.1 million in 2022, then rose by 11.82% to $4.6 million in 2023, then decreased by 10.52% to $4.1 million in 2024, then rose by 9.67% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Non-Current Deferred Tax Liability are $4.5 million (Q3 2025), $4.7 million (Q2 2025), and $4.8 million (Q1 2025).